Validation of a Circulating Tumor DNA‐Based Next‐Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing

BACKGROUND: Characterization of circulating tumor DNA (ctDNA) has been integrated into clinical practice. Although labs have standardized validation procedures to develop single locus tests, the efficacy of on‐site plasma‐based next‐generation sequencing (NGS) assays still needs to be proved. MATERI...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Zoughbi, Wael, Fox, Jesse, Beg, Shaham, Papp, Eniko, Hissong, Erika, Ohara, Kentaro, Keefer, Laurel, Sigouros, Michael, Kane, Troy, Bockelman, Daniel, Nichol, Donna, Patchell, Emily, Bareja, Rohan, Karandikar, Aanavi, Alnajar, Hussein, Cerqueira, Gustavo, Guthrie, Violeta Beleva, Verner, Ellen, Manohar, Jyothi, Greco, Noah, Wilkes, David, Tagawa, Scott, Malbari, Murtaza S., Holcomb, Kevin, Eng, Kenneth Wha, Shah, Manish, Altorki, Nasser K., Sboner, Andrea, Nanus, David, Faltas, Bishoy, Sternberg, Cora N., Simmons, John, Houvras, Yariv, Molina, Ana M., Angiuoli, Samuel, Elemento, Olivier, Mosquera, Juan Miguel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Cancer Diagnostics and Molecular Pathology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571755/
https://www.ncbi.nlm.nih.gov/pubmed/34286887
http://dx.doi.org/10.1002/onco.13905

Ejemplares similares

Ejemplares similares